{"id":858878,"date":"2025-06-10T07:25:32","date_gmt":"2025-06-10T11:25:32","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\/"},"modified":"2025-06-10T07:25:32","modified_gmt":"2025-06-10T11:25:32","slug":"voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\/","title":{"rendered":"Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference"},"content":{"rendered":"
\n

LEXINGTON, Mass., June 10, 2025 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced Alfred W. Sandrock, Jr., M.D., Ph.D., Chief Executive Officer of Voyager, and additional members of management will participate in a pre-recorded fireside chat at the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference.<\/p>\n

An on-demand webcast of the pre-recorded fireside chat will be available and may be accessed from the Investors section of Voyager\u2019s website at\u00a0ir.voyagertherapeutics.com<\/a> starting at 7:00 a.m. ET on June 17, 2025. The on-demand webcast will be archived on the Company\u2019s website for at least 30 days.<\/p>\n

\n About Voyager Therapeutics<\/strong>
\n
Voyager Therapeutics, Inc.\u00a0(Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of \u2013 and ultimately cure \u2013 neurological diseases. Our pipeline includes programs for Alzheimer\u2019s disease, Friedreich\u2019s ataxia, Parkinson\u2019s disease, amyotrophic lateral sclerosis (ALS), and multiple other diseases of the central nervous system. Many of our programs are derived from our TRACER\u2122 AAV capsid discovery platform, which we have used to generate novel capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Some of our programs are wholly owned, and some are advancing with partners including Alexion, AstraZeneca Rare Disease;\u00a0Novartis Pharma AG; and Neurocrine Biosciences, Inc. For more information, visit\u00a0http:\/\/www.voyagertherapeutics.com<\/a>.<\/p>\n

\n Voyager Therapeutics<\/em>
\n
\n \u00ae<\/em>
\n <\/sup>
\n \u00a0is a registered trademark, and TRACER\u2122 is a trademark, of\u00a0Voyager Therapeutics, Inc.\u00a0<\/em>\n <\/p>\n

\n Contacts<\/strong>
\n
Trista Morrison, NACD.DC, tmorrison@vygr.com<\/a>
Investors: Sarah McCabe, smccabe@jpa.com<\/a>
Media: Brooke Shenkin, brooke@scientpr.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

LEXINGTON, Mass., June 10, 2025 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced Alfred W. Sandrock, Jr., M.D., Ph.D., Chief Executive Officer of Voyager, and additional members of management will participate in a pre-recorded fireside chat at the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference. An on-demand webcast of the pre-recorded fireside chat will be available and may be accessed from the Investors section of Voyager\u2019s website at\u00a0ir.voyagertherapeutics.com starting at 7:00 a.m. ET on June 17, 2025. The on-demand webcast will be archived on the Company\u2019s website for at least 30 days. About Voyager Therapeutics Voyager Therapeutics, Inc.\u00a0(Nasdaq: VYGR) is a biotechnology company dedicated to leveraging … <\/p>\n

Continue reading “Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-858878","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nVoyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LEXINGTON, Mass., June 10, 2025 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced Alfred W. Sandrock, Jr., M.D., Ph.D., Chief Executive Officer of Voyager, and additional members of management will participate in a pre-recorded fireside chat at the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference. An on-demand webcast of the pre-recorded fireside chat will be available and may be accessed from the Investors section of Voyager\u2019s website at\u00a0ir.voyagertherapeutics.com starting at 7:00 a.m. ET on June 17, 2025. The on-demand webcast will be archived on the Company\u2019s website for at least 30 days. About Voyager Therapeutics Voyager Therapeutics, Inc.\u00a0(Nasdaq: VYGR) is a biotechnology company dedicated to leveraging … Continue reading "Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-10T11:25:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NTU3MCM2OTgyMjU2IzIwMTg4NDA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference\",\"datePublished\":\"2025-06-10T11:25:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\\\/\"},\"wordCount\":284,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ2NTU3MCM2OTgyMjU2IzIwMTg4NDA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\\\/\",\"name\":\"Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ2NTU3MCM2OTgyMjU2IzIwMTg4NDA=\",\"datePublished\":\"2025-06-10T11:25:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ2NTU3MCM2OTgyMjU2IzIwMTg4NDA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ2NTU3MCM2OTgyMjU2IzIwMTg4NDA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\/","og_locale":"en_US","og_type":"article","og_title":"Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference - Market Newsdesk","og_description":"LEXINGTON, Mass., June 10, 2025 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced Alfred W. Sandrock, Jr., M.D., Ph.D., Chief Executive Officer of Voyager, and additional members of management will participate in a pre-recorded fireside chat at the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference. An on-demand webcast of the pre-recorded fireside chat will be available and may be accessed from the Investors section of Voyager\u2019s website at\u00a0ir.voyagertherapeutics.com starting at 7:00 a.m. ET on June 17, 2025. The on-demand webcast will be archived on the Company\u2019s website for at least 30 days. About Voyager Therapeutics Voyager Therapeutics, Inc.\u00a0(Nasdaq: VYGR) is a biotechnology company dedicated to leveraging … Continue reading \"Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-06-10T11:25:32+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NTU3MCM2OTgyMjU2IzIwMTg4NDA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference","datePublished":"2025-06-10T11:25:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\/"},"wordCount":284,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NTU3MCM2OTgyMjU2IzIwMTg4NDA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\/","name":"Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NTU3MCM2OTgyMjU2IzIwMTg4NDA=","datePublished":"2025-06-10T11:25:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NTU3MCM2OTgyMjU2IzIwMTg4NDA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NTU3MCM2OTgyMjU2IzIwMTg4NDA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-to-present-at-h-c-wainwright-6th-annual-neuro-perspectives-hybrid-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/858878","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=858878"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/858878\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=858878"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=858878"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=858878"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}